HTR2A antagonist 1
HTR2A antagonist 1 (Compound 15f) is a HTR2A antagonist, with an IC50 of 42.79 nM. HTR2A antagonist 1 induces sub-G1 cell cycle arrest and apoptosis in colorectal cancer cells via the activation of p53/p21/caspase 3 signaling. HTR2A antagonist 1 has good liver microsomal stability. HTR2A antagonist 1 can be used for the research of colorectal cancer[1].
Product Specifications
UNSPSC
12352005
Target
5-HT Receptor; Apoptosis
Related Pathways
Apoptosis; GPCR/G Protein; Neuronal Signaling
Field of Research
Cancer
Smiles
O=C(NCC1=CC=C(OCC(O)CN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C=C1)N(CC5=CC=C(F)C=C5)C6CCNCC6.Cl.Cl
Molecular Formula
C35H43Cl2F2N5O4
Molecular Weight
706.65
References & Citations
[1]Kim M, et al. Synthesis and Biological Evaluation of Peripheral HTR2A Antagonists for Colorectal Cancer. J Med Chem. 2025 Jan 23;68 (2) :1716-1730.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Duck Serine Peptidase Inhibitor Kunitz Type 2 ELISA Kit
ZAK (sterile alpha Motif and Leucine zipper Containing Kinase AZK, AZK, MLK7, MLT, MLTK, MRK, mlklak) (FITC)
Human phospholipid scramblase 1, PLSCR1 ELISA Kit